Foghorn Therapeutics

FHTXNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$245.855 M

$4.14 -1.43%

Close of 18 Sept 2026

Revenue

$30.9M

#2875 by revenue

Earnings

-$74.3M

Loss-making

Shares outstanding

59,385,315

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#252Bicycle TherapeuticsBCYC$255.5M
#253Akebia TherapeuticsAKBA$253.7M
#254Foghorn TherapeuticsFHTX$245.9M
#255Cartesian TherapeuticsRNAC$243.0M
#256Whitehawk TherapeuticsWHWK$239.4M

What if Foghorn Therapeutics were worth as much as…

Open the what-if tool →

Gold $30.4T

$511,699.88

Per share 123,599× higher

Bitcoin $1.64T

$27,549.37

Per share 6,654× higher

Nvidia $5.36T

$90,202.55

Per share 21,788× higher

Or at a round number

$500.0M $1.00B $2.00B $5.00B

Where these numbers come from

Share counts and financials for Foghorn Therapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 19 Sept 2026. Read the methodology.